ArticleRheumatology international2020
Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
Article in Rheumatology international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 31 citations in OpenAlex.
- Impact of the COVID-19 pandemic on the quality of care for juvenile idiopathic arthritis patients: insights from Thailand.Orphanet journal of rare diseases · 2024Article
- Management and associated outcomes of COVID-19 infection among Ghanaian autoimmune rheumatic disease patients.Ghana medical journal · 2024Article
- Simultaneous occurrence of knee septic arthritis and coronavirus disease 2019 (COVID-19): A case report.The Egyptian rheumatologist · 2022Article
- Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China.Clinical rheumatology · 2022Article
- Rheumatologists' knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey.Rheumatology international · 2022Article
- Clinical course, chest computed tomography severity score and outcome of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases.The Egyptian rheumatologist · 2022Article
- Public interest in musculoskeletal symptoms and disorders during the COVID-19 pandemic : Infodemiology study.Zeitschrift fur Rheumatologie · 2022Article
- The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey.Rheumatology international · 2022Article
- Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: Case-based review.The Egyptian rheumatologist · 2022Article
- Changes to the practice of pediatric otolaryngology as a consequence of the COVID-19 pandemic.International journal of pediatric otorhinolaryngology · 2022Article
- Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study.Rheumatology international · 2022Article
- Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.Rheumatology international · 2021Observational
- The impact of the COVID-19 pandemic on the field of pediatric rheumatology.Current opinion in rheumatology · 2021Review
- Microscopic polyangiitis associated with coronavirus disease-2019 (COVID-19) infection in an elderly male.The Egyptian rheumatologist · 2021Article
- Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic.The Egyptian rheumatologist · 2021Article
- Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.Rheumatology international · 2021Observational
- Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends.Rheumatology international · 2021Observational
- Reporting Survey Based Studies - a Primer for Authors.Journal of Korean medical science · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 19 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this work is to trace how rheumatologists all over Egypt are approaching the COVID-19 pandemic and what changes it has brought about in the patients' care with special attention to its effect on vulnerable rheumatic disease (RD) patients. This survey further aims to help inform the rheumatology community about the changes in practice during the COVID-19 pandemic. The survey included 26 questions distributed to University staff members across Egypt members of the Egyptian College of Rheumatology (ECR). It takes 5-10 min to fill out. The practice setting of participating rheumatologists included University Teaching Hospitals that are the main rheumatology and clinical immunology service providers for adults and children RD patients. There was an overall agreement across the country in the responses to the survey that took a median time of 7 min to fill in. Potential changes in rheumatology outpatient practice by staff members evolved since the COVID-19 pandemic. None of the university rheumatology staff members has prescribed chloroquine or HCQ to prevent or treat COVID-19 in a non-hospitalized patient who was not previously on it. Twenty-three recommended decrease/avoid NSAIDs if the RD patient had confirmed COVID-19 or symptoms. There is an agreement to the key emerging frontline role of rheumatologists in treating COVID-19. During the pandemic, RD cases requiring admission were dealt with by several modified strategies. The overall agreement among the different university rheumatology departments during such critical situation has provoked the ECR to consider providing provisional guidelines for dealing with RD patients during this global catastrophe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.